Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation

[1]  N. Hannett,et al.  Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. , 2016, Nature chemical biology.

[2]  M. Fann,et al.  Cdk12 is essential for embryonic development and the maintenance of genomic stability , 2015, Cell Death and Differentiation.

[3]  R. Roeder,et al.  RNA polymerase II–associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II , 2015, Science.

[4]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[5]  Jean-Léon Thomas,et al.  Embryonic Stem Cells License a High Level of Dormant Origins to Protect the Genome against Replication Stress , 2015, Stem cell reports.

[6]  Joshy George,et al.  Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.

[7]  Pei Wang,et al.  Cyclin E Deregulation Promotes Loss of Specific Genomic Regions , 2015, Current Biology.

[8]  Tina Lenasi,et al.  Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex , 2015, Nucleic acids research.

[9]  Henry C Kitchener,et al.  Ovarian cancer , 2014, The Lancet.

[10]  Z. Xiao,et al.  A Distinct Expression Pattern of Cyclin K in Mammalian Testes Suggests a Functional Role in Spermatogenesis , 2014, PloS one.

[11]  Lisa Muniz,et al.  3′ end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells , 2014, Genes & development.

[12]  C. Trautwein,et al.  Concurrent deletion of cyclin E1 and cyclin‐dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice , 2014, Hepatology.

[13]  W. Hahn,et al.  Synthetic lethality between CCNE1 amplification and loss of BRCA1 , 2013, Proceedings of the National Academy of Sciences.

[14]  D. Price,et al.  RNA polymerase II transcription elongation control. , 2013, Chemical reviews.

[15]  M. Pagano,et al.  Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis , 2013, Nature Communications.

[16]  J. Blow,et al.  Dormant origins, the licensing checkpoint, and the response to replicative stresses. , 2012, Cold Spring Harbor perspectives in biology.

[17]  M. Marra,et al.  Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II , 2012, Molecular and Cellular Biology.

[18]  Qintong Li,et al.  Cyclin K-containing Kinase Complexes Maintain Self-renewal in Murine Embryonic Stem Cells* , 2012, The Journal of Biological Chemistry.

[19]  Jernej Ule,et al.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. , 2011, Genes & development.

[20]  J. Walter,et al.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. , 2011, Genes & development.

[21]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[22]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[23]  H. Schumny,et al.  Next Generation , 2020 .

[24]  J. Lis,et al.  CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. , 2010, Genes & development.

[25]  Hisao Masai,et al.  Eukaryotic chromosome DNA replication: where, when, and how? , 2010, Annual review of biochemistry.

[26]  Christopher B. Burge,et al.  c-Myc Regulates Transcriptional Pause Release , 2010, Cell.

[27]  S. C. Pruitt,et al.  DNA Damage Response and Tumorigenesis in Mcm2 Deficient Mice , 2010, Oncogene.

[28]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[29]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[30]  J. Julian Blow,et al.  Replication licensing and cancer — a fatal entanglement? , 2008, Nature Reviews Cancer.

[31]  James M. Roberts,et al.  CDK Inhibitors : Cell Cycle Regulators and Beyond , 2008 .

[32]  Amy Freeland,et al.  Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer , 2007, Stem cells.

[33]  E. Dmitrovsky,et al.  Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas , 2007, Proceedings of the National Academy of Sciences.

[34]  James M. Roberts,et al.  Kinase-independent function of cyclin E. , 2007, Molecular cell.

[35]  H. Phatnani,et al.  Phosphorylation and functions of the RNA polymerase II CTD. , 2006, Genes & development.

[36]  J. Diffley,et al.  CDKs Promote DNA Replication Origin Licensing in Human Cells by Protecting Cdc6 from APC/C-Dependent Proteolysis , 2005, Cell.

[37]  James M. Roberts,et al.  A mouse model for cyclin E-dependent genetic instability and tumorigenesis. , 2005, Cancer cell.

[38]  K. Helin,et al.  Human Geminin promotes pre‐RC formation and DNA replication by stabilizing CDT1 in mitosis , 2004, The EMBO journal.

[39]  Bruce Stillman,et al.  Deregulation of cyclin E in human cells interferes with prereplication complex assembly , 2004, The Journal of cell biology.

[40]  L. Pevny,et al.  SOX2 Functions to Maintain Neural Progenitor Identity , 2003, Neuron.

[41]  R. Ozols.  Ovarian Cancer: American Cancer Society Atlas of Clinical Oncology , 2003 .

[42]  S. Reed,et al.  Deregulated cyclin E induces chromosome instability , 1999, Nature.

[43]  S. Elledge,et al.  Human Cyclin K, a Novel RNA Polymerase II-Associated Cyclin Possessing Both Carboxy-Terminal Domain Kinase and Cdk-Activating Kinase Activity , 1998, Molecular and Cellular Biology.

[44]  H. Nishitani,et al.  Chromatin fractionation analysis of licensing factors in mammalian cells. , 2014, Methods in molecular biology.

[45]  A. Perrakis,et al.  Cdt1 and geminin in DNA replication initiation. , 2012, Sub-cellular biochemistry.

[46]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[47]  H. Willenbring,et al.  A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice , 2008, Nature Protocols.

[48]  B. Tye,et al.  A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice , 2007, Nature Genetics.

[49]  Yusuke Nakamura,et al.  Cyclin K as a direct transcriptional target of the p53 tumor suppressor. , 2002, Neoplasia.